Showing results (81-90 of 280) with videos related to
Sort By:
Pageof 28
Research Communications in Chemical Pathology and Pharmacology|January 1, 1978
Adenosine as a prostaglandin antagonist. Possible mechanism of the defect in combined immunodeficiency disease due to adenosine deaminase deficiencyR A Karmali, D F Horrobin, A I Ally, et al.Prostaglandins and Medicine|August 1, 1978
A defect in thromboxane A2 synthesis may be a factor predisposing to cancerD F Horrobin, R A Karmali, M S Manku, et al.Canadian Journal of Physiology and Pharmacology|June 1, 1978
Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2A I Ally, D F Horrobin, M S Manku, et al.Annals of the New York Academy of Sciences|January 1, 1979
Thymic changes in muscular dystrophy and evidence for an abnormality related to prostaglandin synthesis or actionD F Horrobin, R O Morgan, R A Karmali, et al.Prostaglandins and Medicine|July 1, 1978
Ultra-violet radiation and 8-methoxypsoralen have actions similar to those of known inhibitors of thromboxane A2 synthesis in rat mesenteric blood vesselsM S Manku, D F Horrobin, M Oka, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1995
Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease?D F HorrobinLancet (London, England)|April 30, 1977
Schizophrenia as a prostaglandin deficiency diseaseD F HorrobinMedical Hypotheses|July 1, 1984
Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndromeD F HorrobinMedical Hypotheses|September 1, 1981
Loss of delta-6-desaturase activity as a key factor in agingD F HorrobinWiener Klinische Wochenschrift|April 14, 1989
Essential fatty acids and the complications of diabetes mellitusD F HorrobinPageof 28